Evaluating the Direct and Indirect Effects of SF-36 Domains Score on Two Main Factors in Diabetic Patients with Path Analysis: Health-Related Quality of Life Study

Open access


Background and aims: Diabetes mellitus (DM) patients have a lower quality of life. This study aimed to examine the direct and indirect effect of eight domains score of the SF-36 questionnaire on two main factors, i.e., overall physical health (GH_M) and overall mental health (MH_M), in DM patients. To the best of our knowledge, this issue has been rarely studied so far.

Material and method: A total of 1037 DM patients filled out the Persian version of the SF-36 questionnaire. The path analysis was used in this study.

Results: In this research, only social functioning (SF) domain has significantly lower the men compared to women (P=0.06). Physical functioning (PF), bodily pain (BP), general health (GH) and vitality (VT) have a negative significant direct effect on the GH_M factor. GH domain also has a positive indirect and total effect on MH_M factor, and other domains have no significant total effect on MH_M factor.

Conclusion: It is better that physicians, focus on regulating physical activity and reducing body pain in diabetes patients, which have the most direct impact on HRQoL, to achieve a more effective outcome in improving quality of life in this patient.

1.American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 23: S32, 2000

2. Esteghamati A, Gouya MM, Abbasi M et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: the national survey of risk factors for non-communicable diseases of Iran. Diabetes Care 31(1): 96-8, 2008

3. Nyanzi R, Wamala R, Atuhaire LK. Diabetes and quality of life: a Ugandan perspective. J Diabetes Res 2014: p402012, 2014

4. Al Hayek AA, Robert AA, Al Saed A, Alzaid AA, Al Sabaan AS. Factors associated with health-related quality of life among Saudi patients with type 2 diabetes mellitus: a cross-sectional survey. Diabetes Metab J 38(3): 220-229, 2014

5. Daniele TM, Bruin VM, Oliveira DS, Pompeu CM, Forti AC. Associations among physical activity, comorbidities, depressive symptoms and health-related quality of life in type 2 diabetes. Arg Bras Endocrinol Metab 57(1): 44-50, 2013

6. Boyer JG, Earp JA. The development of an instrument for assessing the quality of life of people with diabetes: Diabetes-39. Med Care 35(5): 440-453, 1997

7. Weinberger M, Kirkman MS, Samsa GP et al. The relationship between glycemic control and health-related quality of life in patients with non-insulindependent diabetes mellitus. Med Care 32(12): 1173-1181, 1994

8. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rew 15(3): 205-218, 1999

9. World Health Organization. Constitution of the world health organization. 1995.

10. Testa MA. Quality-of-life assessment in diabetes research: interpreting the magnitude and meaning of treatment effects. Diabetes Spectrum 13(1): 29-35, 2000

11. Hörnquist JO, Wikby A, Andersson PO, Dufva AM. Insulin-pen treatment, quality of life and metabolic control: retrospective intra-group evaluations. Diabetes Res Clin Pract 10(3): 221-230, 1990

12. Andersson PO, Wikby A, Sternstomb U, Horniquist JO. Pen injection and change in metabolic control and quality of life in insulin dependent diabetes mellitus. Diabetes Res Clin Pract 36(3): 169-172, 1997

13. Testa MA, Simonson DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial. Jama 280(17): 1490-1496, 1998

14. Golicki D, Dudsinzka M, Zwolak A, Tarach JS. Quality of life in patients with type 2 diabetes in Poland-comparison with the general population using the EQ-5D questionnaire. Adv Clin Exp Med 24(1): 139-46, 2015

15. Ware Jr JE. SF-36 health survey update. Spine 25(24): 3130-3139, 2000

16. Bradley C, Lewis K. Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes. Diabetic Med 7(5): 445-451, 1990

17. Jacobson AM, De Groot M, Samson JA. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care 17(4): 267-274, 1994

18. Wändell PE. Quality of life of patients with diabetes mellitus an overview of research in primary health care in the Nordic countries. Scand J Prim Health Care 23(2): 68-74, 2005

19. Schram MT, Baan CA, Pouwer F. Depression and quality of life in patients with diabetes: a systematic review from the European depression in diabetes (EDID) research consortium. Curr Diabetes Rew 5(2): 112-119, 2009

20. Glasgow RE, Ruggiero L, Eakin EG, Dryfoos J, Chobanian L. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care 20(4): 562-567, 1997

21. Ware Jr JE. How to score the revised MOS short-form health scale (SF-36®). New Engl Med Centr Hosp 10: 17-18, 1988

22. Ware Jr JE Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 30 (6): 473-483, 1992

23. Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B. The Short Form Health Survey (SF-36): translation and validation study of the Iranian version. Qual Life Res 14(3): 875-882, 2005

24. Jafari H, Lahsaeizadeh S, Jafari P, Karimi M. Quality of life in thalassemia major: reliability and validity of the Persian version of the SF-36 questionnaire. J Postgard Med 54(4): 273-5, 2008

25. Hamta A, Khalilian AR, Farhadi R, Ranjbaran H. Path Analysis of the Risk of Low Birth Weight for Multipara. Iran Red Crescent Med J 15(6): 462-6, 2013

26. Vasconcelos AG, Almeida RM, Nobre FF. The path analysis approach for the multivariate analysis of infant mortality data. Ann Epidemiol 8(4): 262-71, 1988

27. Goldsmith JR. Paths of association in epidemiological analysis: application to health effects of environmental exposures. Int J Epidemiol 6(4): 391-399, 1977

28. Goldsmith JR. Berglund K. Epidemiological approach to multiple factor interactions in pulmonary disease: the potential usefulness of path analysis. Ann N Y Acad Sci 221: 361-375, 1974

29. Bagheri Z, Jafari P, Faghih M, Allahyari E, Dehesh T. Testing measurement equivalence of the SF-36 questionnaire across patients on hemodialysis and healthy people. Int Urol Nephrol 47(12): 2013-2021, 2015

30. Gift HC, Atchison KA. Oral health, health, and health-related quality of life. Med Care 30(1): NS57-NS77, 1995

31. Sepúlveda E, Poinhos R, Constante M, Pais-Ribiero J, Freitas P, Carvalho D. Health-related quality of life in type 1 and type 2 diabetic patients in a Portuguese central public hospital. Diab Metab Syndr Obes 8: 219, 2015

32. Klein BE, Klein R, Moss SE. Self-rated health and diabetes of long duration: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care 21(2): 236-240, 1998

33. Peyrot M, Rubin RR. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care 20(4): 85-590, 1997

34. Goldney RD, Phillips PJ, Fishel LJ, Wilson DH. Diabetes, depression, and quality of life: a population study. Diabetes Care 27(5): 1066-1070, 2004

35. Kakhki AD. Health-related quality of life of diabetic patients in Tehran. Int J Endocrinol metab 11(4): e7945, 2013

36. Olobatuyi ME. A user's guide to path analysis. Lanham, MD : University Press of America, 2006

Romanian Journal of Diabetes Nutrition and Metabolic Diseases

The Journal of Romanian Society of Diabetes Nutrition and Metabolic Diseases

Journal Information

CiteScore 2017: 0.11

SCImago Journal Rank (SJR) 2017: 0.122
Source Normalized Impact per Paper (SNIP) 2017: 0.077


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 37 37 18
PDF Downloads 50 50 14